VANECK BIONIC ENGINEERING UCITS ETF - USD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - CHF | -.--% |
|
-.--% | -.--% |
Investment objective
VanEck?s Bionic Engineering ETF tracks the performance of the portfolio of innovative companies delivering medical, dental or vision-related implants, bioprinting, prosthesis, or preservation of organs and tissue.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 329.5 AUD | +0.52% | +3.89% | +10.33% | -.--% | ||
| 266.8 CHF | -0.11% | +4.46% | -2.77% | -.--% | ||
| 119.6 CHF | +0.89% | -2.80% | -11.84% | -.--% | ||
| 320.4 DKK | 0.00% | -0.19% | +8.24% | -.--% | ||
| 81.55 USD | -0.43% | +0.82% | -1.01% | -.--% | ||
| 33.36 EUR | 0.00% | +6.14% | +6.45% | -.--% | ||
| 129,200 KRW | 0.00% | -0.54% | -1.37% | -.--% | ||
| 1.72 HKD | +0.58% | 0.00% | -26.81% | -.--% | ||
| 6.53 HKD | -2.25% | +3.82% | -22.45% | -.--% | ||
| 10.6 USD | -21.94% | -18.27% | -29.85% | -.--% | ||
More news
In partnership with
Description
| IE0005TF96I9 | |
|---|---|
| Total Expense Ratio | 0.55% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | MVIS Global Bionic Healthcare ESG Index (NTR) - USD |
Features and characteristics
| Jurisdiction | |
| Replication Method | |
| Replication Model | |
| Date of creation |
2022-12-01
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 2024-04-29 )
| AuM (EUR) | 0 M€ |
|---|---|
| AuM 1M | 0 M€ |
| AuM 3 months | 0 M€ |
| AuM 6 months | 0 M€ |
| AuM 12 months | 0 M€ |
- Stock Market
- ETF
- CYBO ETF